Samsung Biologics (Korea) Market Value
207940 Stock | 929,000 29,000 3.03% |
Symbol | Samsung |
Samsung Biologics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Samsung Biologics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Samsung Biologics.
08/29/2024 |
| 11/27/2024 |
If you would invest 0.00 in Samsung Biologics on August 29, 2024 and sell it all today you would earn a total of 0.00 from holding Samsung Biologics Co or generate 0.0% return on investment in Samsung Biologics over 90 days. Samsung Biologics is related to or competes with Hanjin Transportation, Daekyung Machinery, Hana Technology, Alton Sports, Global Standard, Dong A, and Daewoo Engineering. More
Samsung Biologics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Samsung Biologics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Samsung Biologics Co upside and downside potential and time the market with a certain degree of confidence.
Downside Deviation | 1.83 | |||
Information Ratio | (0.05) | |||
Maximum Drawdown | 8.27 | |||
Value At Risk | (2.24) | |||
Potential Upside | 2.57 |
Samsung Biologics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Samsung Biologics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Samsung Biologics' standard deviation. In reality, there are many statistical measures that can use Samsung Biologics historical prices to predict the future Samsung Biologics' volatility.Risk Adjusted Performance | 0.0332 | |||
Jensen Alpha | 0.0296 | |||
Total Risk Alpha | (0.18) | |||
Sortino Ratio | (0.04) | |||
Treynor Ratio | 0.3751 |
Samsung Biologics Backtested Returns
Samsung Biologics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0317, which indicates the firm had a -0.0317% return per unit of risk over the last 3 months. Samsung Biologics Co exposes twenty-nine different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Samsung Biologics' Semi Deviation of 1.1, risk adjusted performance of 0.0332, and Coefficient Of Variation of 2669.98 to confirm the risk estimate we provide. The entity has a beta of 0.12, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Samsung Biologics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Samsung Biologics is expected to be smaller as well. At this point, Samsung Biologics has a negative expected return of -0.0411%. Please make sure to validate Samsung Biologics' coefficient of variation, jensen alpha, and the relationship between the downside deviation and standard deviation , to decide if Samsung Biologics performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.41 |
Modest reverse predictability
Samsung Biologics Co has modest reverse predictability. Overlapping area represents the amount of predictability between Samsung Biologics time series from 29th of August 2024 to 13th of October 2024 and 13th of October 2024 to 27th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Samsung Biologics price movement. The serial correlation of -0.41 indicates that just about 41.0% of current Samsung Biologics price fluctuation can be explain by its past prices.
Correlation Coefficient | -0.41 | |
Spearman Rank Test | -0.25 | |
Residual Average | 0.0 | |
Price Variance | 664 M |
Samsung Biologics lagged returns against current returns
Autocorrelation, which is Samsung Biologics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Samsung Biologics' stock expected returns. We can calculate the autocorrelation of Samsung Biologics returns to help us make a trade decision. For example, suppose you find that Samsung Biologics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
Samsung Biologics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Samsung Biologics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Samsung Biologics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Samsung Biologics stock over time.
Current vs Lagged Prices |
Timeline |
Samsung Biologics Lagged Returns
When evaluating Samsung Biologics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Samsung Biologics stock have on its future price. Samsung Biologics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Samsung Biologics autocorrelation shows the relationship between Samsung Biologics stock current value and its past values and can show if there is a momentum factor associated with investing in Samsung Biologics Co.
Regressed Prices |
Timeline |
Pair Trading with Samsung Biologics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Samsung Biologics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Samsung Biologics will appreciate offsetting losses from the drop in the long position's value.Moving together with Samsung Stock
The ability to find closely correlated positions to Samsung Biologics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Samsung Biologics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Samsung Biologics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Samsung Biologics Co to buy it.
The correlation of Samsung Biologics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Samsung Biologics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Samsung Biologics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Samsung Biologics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Samsung Stock
Samsung Biologics financial ratios help investors to determine whether Samsung Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Samsung with respect to the benefits of owning Samsung Biologics security.